PathoQuest Webinar (Archived): It’s Better to Know Now vs. Later: Genetic Characterisation of Gene Therapy Vectors & Vaccines by NGS

Webinars PathoQuest Webinar (Archived): It’s Better to Know Now vs. Later: Genetic Characterisation of Gene Therapy Vectors & Vaccines by NGS Listen to an archived version of our recent webinar where Colette Côté, PhD provides insights on genetic...

PathoQuest Webinar (Archived): The future is now for NGS biosafety testing: Navigating revisions to ICH Q5A

Webinars PathoQuest Webinar (Archived): The future is now for NGS biosafety testing: Navigating revisions to ICH Q5A Return to the list of webinars Listen to an archived version of our recent webinar where PathoQuest and other experts in the field to gain insights on...

PathoQuest in BioPharma Asia webinar: CMC Progression from Early to Late Phase – Practical Considerations for Gene Therapy

Webinars PathoQuest in BioPharma Asia webinar: CMC Progression from Early to Late Phase – Practical Considerations for Gene Therapy Return to the list of webinars The principles for developing traditional biologics are well established but do not always translate well...

PathoQuest in AdeBiotech’s webinar on high throughput sequencing applications – 2nd edition (in French)

Webinars PathoQuest in AdeBiotech’s webinar on high throughput sequencing applications – 2nd edition (in French) Return to the list of webinars Watch the replay See the...

PathoQuest in BioPharma Asia webinar: APPLICATION OF NEXT GENERATION SEQUENCING (NGS) BASED METHODS FOR DETECTION OF VIRAL CONTAMINANTS IN BIOMANUFACTURING

Webinars PathoQuest in BioPharma Asia webinar: APPLICATION OF NEXT GENERATION SEQUENCING (NGS) BASED METHODS FOR DETECTION OF VIRAL CONTAMINANTS IN BIOMANUFACTURING Return to the list of webinars Contamination of a biological product with viruses, potentially harmful...

Exclusive study “Use of NGS to replace animal tests for the viral safety of biologics”

Preferred Events Exclusive study “Use of NGS to replace animal tests for the viral safety of biologics” Industry stakeholders need rapid and robust testing strategies to ensure their products and patients’ safety. Doing so they are seeking long-term...